Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

WhatsApp Messaging Versus SMART Goal-setting to Improve Therapeutic Adherence in Patients With Type 2 Diabetes in Primary Care: a Quasi-experimental Study

NCT07837856 is registered in ClinicalTrials.gov with Instituto Mexicano del Seguro Social as lead sponsor.

NCT NCT07837856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07837856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
WhatsApp Messaging Versus SMART Goal-setting to Improve Therapeutic Adherence in Patients With Type 2 Diabetes in Primary Care: a Quasi-experimental Study
Lead sponsor
Instituto Mexicano del Seguro Social
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2024
Completion date
December 30, 2025
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete type 2, diabetes mellitus, type 2/prevention & control, treatment adherence